Improving adherence in ulcerative colitis (UC) patients on 5-ASA.

Completed

• Conditions: inflammatory bowel disease; ulcerative colitis; 10017969

• Registration Number: NL-OMON40052
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 220

Inclusion Criteria

Age>18 and <80 years
Confirmed (clinical and histological) diagnosis of ulcerative colitis, either left sided or pancolitis (Montreal classification)
Patients in remission defined as a score of <5 SCCAI
5-ASA monotherapy or combination therapy with local therapy (suppositories/enemas/foam)
Patients in possession of mobile phone

Exclusion Criteria

Pregnancy
Concomitant use of immunosuppressives
Use of immunosuppressives in the prior 3 months
No access to mobile phone

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Adherence measured as 5-ASA-metabolites in urine </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1. quality of life<br /><br>2. clinical as well as endoscopic remission<br /><br>3. costs<br /><br>4. safety<br /><br>5. adherence as measured with questionnaires<br /><br>in UC patients on 5-ASA</p><br>